December 23, 2025

New ALS drug stabilizes decline with a trend toward impro

Long-term use of tofersen slows ALS disease progression in people with a genetic subtype, provides hope for treating other forms of ALS by Julia Evangelou Strait•December 22, 2025 Huy Mach Rickey Malloy (left), who receives tofersen treatment for SOD1-ALS at WashU Medicine, plays a round of golf with his wife, Jenny, and their son, Kash. Long-term […]

New ALS drug stabilizes decline with a trend toward impro Read More »

AI tracks nearly 100 years of aging research, revealing key trends and gaps

“This study outlines shifting priorities and translational gaps in aging research and offers a scalable, data-driven alternative to conventional reviews.” Peer-Reviewed Publication Impact Journals LLC image: Figure 6. Mapping underexplored connections in the aging research literature through semantic overlap analysis. (A) Heatmap of average TF-IDF score of the top 20 most significant words from each cluster when

AI tracks nearly 100 years of aging research, revealing key trends and gaps Read More »

OpenAI Says AI Browsers May Face Permanent Security Weakness, Vulnerability to Prompt Injection Attacks

OpenAI has officially acknowledged a worrying reality: their Atlas AI browser, like all AI-powered browsers, will never be completely safe from prompt injection attacks. Most likely.  Example of how a prompt injection attack text could look like. Image credit: OpenAI Key Takeaways: Prompt injection attacks against AI browsers cannot be fully eliminated, only managed through continuous defense

OpenAI Says AI Browsers May Face Permanent Security Weakness, Vulnerability to Prompt Injection Attacks Read More »

Signature neural patterns may help predict recovery from traumatic brain injury

by Mass General Brigham edited by Gaby Clark, reviewed by Robert Egan  Editors’ notes LOOCV Methods Schematic. Credit: Proceedings of the National Academy of Sciences (2025). DOI: 10.1073/pnas.2518159122 After traumatic brain injury (TBI), some patients may recover completely, while others retain severe disabilities. Accurately evaluating prognosis is challenging in patients on life-sustaining therapy. Though resting-state functional MRI (rs-fMRI) can assess neurological activity

Signature neural patterns may help predict recovery from traumatic brain injury Read More »

Purple Power: Evidence-Based Health Benefits of Anthocyanin-Rich Diets

By Pooja Toshniwal PahariaReviewed by Benedette Cuffari, M.Sc. Introduction Top ACN-rich foods Mechanisms of action Benefits for brain health Cardiovascular effects Skin health benefits Optimal intake and safety References Further reading Purple foods aren’t just pretty! Here’s what anthocyanins are actually doing inside your body, and why the best evidence points to specific heart and brain benefits

Purple Power: Evidence-Based Health Benefits of Anthocyanin-Rich Diets Read More »

Prebiotic microcapsules deliver pterostilbene to the colon to alleviate ulcerative colitis

Frontiers JournalsDec 23 2025 A team led by clinicians and engineers has wrapped the plant-derived polyphenol pterostilbene (PSB) into prebiotic alginate/resistant-starch microcapsules coated with chitosan and shown that oral administration dampens dextran-sulfate-sodium (DSS) colitis in mice. The work, released online in Engineering, demonstrates that the 200-μm spheres escape gastric breakdown, accumulate in the colon for at

Prebiotic microcapsules deliver pterostilbene to the colon to alleviate ulcerative colitis Read More »

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Interview conducted by Lauren HardakerDec 23 2025 Thought LeaderDr Bryony HendersonMedical Director for UK & USMedExpress In this interview, News Medical speaks with Dr Bryony Henderson, Medical Director for the UK and US at MedExpress, about the evolving role of GLP‑1 agonists in obesity care and the future of metabolic health treatments. Please introduce yourself and talk a little about

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson Read More »

“See-and-treat” solution for stroke via quantum dot-engineered extracellular vesicles derived from human exfoliated deciduous teeth stem cells

Peer-Reviewed Publication KeAi Communications Co., Ltd. image: Engineered Stem Cell Vesicles for Real-Time Stroke Imaging and Therapy view more  Credit: Xu Duan et al Ischemic stroke remains a leading global cause of disability and mortality, and a major challenge in stroke treatment is “reperfusion injury”—where return of blood flow causes oxidative stress and inflammation, further damaging

“See-and-treat” solution for stroke via quantum dot-engineered extracellular vesicles derived from human exfoliated deciduous teeth stem cells Read More »

Immune cell ‘fuel’ shortages shape atherosclerosis, scientists reveal

by University of Eastern Finland edited by Lisa Lock, reviewed by Robert Egan  Editors’ notes Gln metabolism remodels macrophage functions and atherosclerotic lesions. Credit: Nature Metabolism (2025). DOI: 10.1038/s42255-025-01354-2 Two complementary studies reveal how an insufficient supply of energy in macrophages, key immune cells in artery walls, drives the progression of atherosclerosis—and how this knowledge could lead to better diagnostics

Immune cell ‘fuel’ shortages shape atherosclerosis, scientists reveal Read More »

Key phospholipid points to potential treatment for vascular dementia

by University of Vermont edited by Sadie Harley, reviewed by Robert Egan  Editors’ notes The microvasculature of a brain imaged using two-photon laser scanning microscopy. Credit: Asser Bedair, Ph.D., Larner College of Medicine A possible new treatment for impaired brain blood flow and related dementias is on the horizon. Research by scientists at the University of Vermont Robert

Key phospholipid points to potential treatment for vascular dementia Read More »

Scroll to Top